The identification of ‘boosters’ that drive gene overexpression directly in a CAR construct provides a simple and scalable strategy for developing effective CAR-NK cell therapies for solid tumours.
Lex: FT's flagship investment column
，推荐阅读51吃瓜获取更多信息
PST — 6 a.m.
configurable: true,
，更多细节参见旺商聊官方下载
Последние новости，这一点在safew官方版本下载中也有详细论述
Copyright © 1997-2026 by www.people.com.cn all rights reserved